Showing results (2321-2330 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|April 8, 2011
Immunosuppressive treatments in acute myocardial infarction and strokeLizzia Raffaghello, Giovanna Bianchi, Vito PistoiaCurrent Pharmaceutical Biotechnology|April 8, 2011
Roles of connexins in atherosclerosis and ischemia-reperfusion injurySandrine Morel, Brenda R KwakCurrent Pharmaceutical Biotechnology|June 11, 2011
Modeling Follicle Stimulating Hormone (FSH) levels in serum for controlled ovarian hyperstimulation II: the underlying mechanismsDavid H McCulloh, Jose M Colon, Peter G McGovernCurrent Pharmaceutical Biotechnology|June 11, 2011
Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysisE M Kolibianakis, C A Venetis, J Bontis, et al.Current Pharmaceutical Biotechnology|May 31, 2011
Structures of TGF-β receptor complexes: implications for function and therapeutic intervention using ligand trapsAndrew P Hinck, Maureen D O'Connor-McCourtCurrent Pharmaceutical Biotechnology|November 2, 2011
History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agentsWilliam C CampbellCurrent Pharmaceutical Biotechnology|November 2, 2011
Pharmacokinetic features of the antiparasitic macrocyclic lactonesQuintin A McKellar, Cengiz GokbulutCurrent Pharmaceutical Biotechnology|November 2, 2011
Macrocyclic lactones and cellular transport-related drug interactions: a perspective from in vitro assays to nematode control in the fieldA Lifschitz, M Ballent, C LanusseCurrent Pharmaceutical Biotechnology|November 2, 2011
Recent developments in the analysis of avermectin and milbemycin residues in food safety and the environmentMartin Danaher, Wolfgang Radeck, Lucija Kolar, et al.Current Pharmaceutical Biotechnology|November 2, 2011
Toxicity in animals: target speciesK N WoodwardPageof 303